104 related articles for article (PubMed ID: 7632174)
21. Increased cytotoxicity of 2',2'-difluoro-2'-deoxycytidine in human leukemic cell-lines after a preincubation with cyclopentenyl cytosine.
Verschuur AC; Van Gennip AH; Leen R; Van Kuilenburg AB
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1517-21. PubMed ID: 15571289
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells.
Bouffard DY; Momparler LF; Momparler RL
Anticancer Drugs; 1994 Apr; 5(2):223-8. PubMed ID: 7519483
[TBL] [Abstract][Full Text] [Related]
23. Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models.
Van Bree C; Barten-Van Rijbroek AD; Leen R; Rodermond HM; Van Kuilenburg AB; Kal HB
Int J Oncol; 2009 Mar; 34(3):813-9. PubMed ID: 19212686
[TBL] [Abstract][Full Text] [Related]
24. Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in rats.
Schimmel K; Bennink R; de Bruin K; Leen R; Sand K; van den Hoff M; van Kuilenburg A; Vanderheyden JL; Steinmetz N; Pfaffendorf M; Verschuur A; Guchelaar HJ
Arch Toxicol; 2005 May; 79(5):268-76. PubMed ID: 15902424
[TBL] [Abstract][Full Text] [Related]
25. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB
Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994
[TBL] [Abstract][Full Text] [Related]
26. Sensitizing human colon carcinoma HT-29 cells to cisplatin by cyclopentenylcytosine, in vitro and in vivo.
Gharehbaghi K; Szekeres T; Yalowitz JA; Fritzer-Szekeres M; Pommier YG; Jayaram HN
Life Sci; 2000 Nov; 68(1):1-11. PubMed ID: 11132239
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of the experimental cytotoxic drug cyclopentenyl cytosine and its metabolite in plasma with HPLC tandem mass spectrometry.
Schimmel K; van Lenthe H; Leen R; Kulik W; Verschuur A; Guchelaar HJ; van Kuilenburg A
Biomed Chromatogr; 2008 Dec; 22(12):1368-73. PubMed ID: 18661479
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
Moyer JD; Malinowski NM; Treanor SP; Marquez VE
Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
[TBL] [Abstract][Full Text] [Related]
29. Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy.
Verschuur AC; Van Gennip AH; Leen R; Muller EJ; Elzinga L; Voûte PA; Van Kuilenburg AB
Eur J Cancer; 2000 Mar; 36(5):627-35. PubMed ID: 10738128
[TBL] [Abstract][Full Text] [Related]
30. Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360).
Peters GJ; Smid K; Vecchi L; Kathmann I; Sarkisjan D; Honeywell RJ; Losekoot N; Ohne O; Orbach A; Blaugrund E; Jeong LS; Lee YB; Ahn CH; Kim DJ
Invest New Drugs; 2013 Dec; 31(6):1444-57. PubMed ID: 24048768
[TBL] [Abstract][Full Text] [Related]
31. CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
Huang M; Wang Y; Collins M; Graves LM
Leukemia; 2004 Nov; 18(11):1857-63. PubMed ID: 15385935
[TBL] [Abstract][Full Text] [Related]
32. Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemia.
Schimmel KJ; Nijmeijer BA; van Schie ML; Falkenburg JH; Guchelaar HJ
Leuk Res; 2007 Nov; 31(11):1545-51. PubMed ID: 17459472
[TBL] [Abstract][Full Text] [Related]
33. In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors.
Viola JJ; Agbaria R; Walbridge S; Oshiro EM; Johns DG; Kelley JA; Oldfield EH; Ram Z
Cancer Res; 1995 Mar; 55(6):1306-9. PubMed ID: 7882327
[TBL] [Abstract][Full Text] [Related]
34. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase.
Kang GJ; Cooney DA; Moyer JD; Kelley JA; Kim HY; Marquez VE; Johns DG
J Biol Chem; 1989 Jan; 264(2):713-8. PubMed ID: 2910861
[TBL] [Abstract][Full Text] [Related]
35. Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
Huang M; Whang P; Lewicki P; Mitchell BS
Mol Pharmacol; 2011 Jul; 80(1):40-8. PubMed ID: 21464199
[TBL] [Abstract][Full Text] [Related]
36. A single point mutation in CTP synthetase of Chlamydia trachomatis confers resistance to cyclopentenyl cytosine.
Wylie JL; Wang LL; Tipples G; McClarty G
J Biol Chem; 1996 Jun; 271(26):15393-400. PubMed ID: 8663065
[TBL] [Abstract][Full Text] [Related]
37. Formulation, quality control and shelf life of the experimental cytostatic drug cyclopentenyl cytosine.
Schimmel K; Guchelaar HJ; van Kan E
Drug Dev Ind Pharm; 2006 Apr; 32(4):497-503. PubMed ID: 16638688
[TBL] [Abstract][Full Text] [Related]
38. Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?
van Bree C; van Kuilenburg AB
Leuk Res; 2008 Feb; 32(2):201-2. PubMed ID: 17681375
[No Abstract] [Full Text] [Related]
39. Mitochondrial effects of the guanidino group-containing cytostatic drugs, m-iodobenzylguanidine and methylglyoxal bis (guanylhydrazone).
Loesberg C; Van Rooji H; Romijn JC; Smets LA
Biochem Pharmacol; 1991 Jul; 42(4):793-8. PubMed ID: 1867636
[TBL] [Abstract][Full Text] [Related]
40. Ribo- and deoxyribonucleoside effect on 3'-amino-2',3'-dideoxycytidine-induced cytotoxicity in cultured L1210 cells.
Mancini WR; Lin TS
Biochem Pharmacol; 1983 Aug; 32(16):2427-32. PubMed ID: 6615544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
